-
Studies have shown that less and more sleep can lead to cognitive decline
Time of Update: 2021-11-01
Through many years of tracking the cognitive function of a group of elderly people, and analyzing the levels of Alzheimer’s disease-related proteins and brain activity during sleep, the researchers have generated information that can help unlock sleep, Alzheimer’s disease and cognitive function.
-
Animal-derived drug-resistant genes and resistant bacteria can accumulate in dust for a long time
Time of Update: 2021-11-01
Professor Ying Guangguo's Antibiotic Resistance Research Group, Bai Hong and others from the School of Environment of South China Normal University studied the transmission mode and exposure risk of ARGs and ARBs (especially zoonotic pathogens) transmitted in the atmosphere in chicken farms and dairy farms.
-
Chinese scholars propose innovative treatment plans for Chinese liver cancer patients
Time of Update: 2021-11-01
In recent years, Chinese scholars have proposed hepatic arterial infusion chemotherapy (FOLFOX-HAIC) with fluorouracil, leucovorin and oxaliplatin regimens for the treatment of large liver cancer .
In 2017, Shi Ming’s team initially revealed the safety and effectiveness of FOLFOX-HAIC in the treatment of large liver cancer in a phase II study .
-
A nano-enzyme capsule can improve the antibacterial effect of diabetic wounds
Time of Update: 2021-11-01
The scientific research team of Changsha University of Science and Technology has constructed a nanoenzyme capsule composed of platinum nanoenzymes, bacterial targeting nucleic acid aptamers, glucose oxidase and hyaluronic acid, which can provide hydrogen peroxide and self-adjust the acidity of the microenvironment.
-
Deep processed foods impair memory
Time of Update: 2021-11-01
The researchers also found that adding the omega-3 fatty acid DHA to the processed diet can prevent memory problems and almost completely reduce the inflammatory effects in elderly rats .
-
The high temperature adaptive growth mechanism of large edible and medicinal bacteria revealed
Time of Update: 2021-11-01
trogii ) High-quality haplotype genome, and found that the tandem repeated heat shock protein gene cluster in the genome is related to the formation of heat resistance of the bacteria .
-
Scientists reveal the pathogenesis of hepatomegaly and liver cancer caused by glycogen accumulation
Time of Update: 2021-11-01
This work found that early liver tumor cells use the extracted glucose to synthesize glycogen as energy storage, and inhibit the activity of the Hippo signaling pathway through liquid-liquid separation, thereby driving the occurrence and development of tumors .
-
Scientists reach a new international consensus on the concept of epigenetics
Time of Update: 2021-11-01
In 2019, the International Association of Probiotics and Prebiotics (ISAPP) published a consensus on the concept of epigenes in Nature Reviews Gastroenterology & Hepatology , defining epigenes as “to host Inactivated bacteria and/or bacterial components that play a beneficial role" .
-
A multinational pharmaceutical company continues to deepen its strategic layout in China, and its global R&D China center settles in Shanghai
Time of Update: 2021-10-21
On October 11, AstraZeneca, a multinational pharmaceutical company, officially opened its Global R&D China Center in Shanghai .
It is reported that, in addition to AstraZeneca, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Roche and other companies are actually deploying global new drug research and development through the strong domestic support for innovative drug research and development .
-
Shanghai Lu Xiangyi's explosion-proof centrifuge was successfully sent to the biopharmaceutical industry to escort the safe production of pharmaceuticals!
Time of Update: 2021-10-21
According to the working principle of the DL-8M explosion-proof centrifuge, the equipment uses the difference in solid-liquid specific gravity and relies on the centrifugal force field to expand it thousands of times.
. Shanghai Lu Xiangyi designed a nitrogen protection device to meet the requirements of high explosion-proof occasions, and it is well used .
-
In order to accelerate innovation and upgrading, this pharmaceutical company has successively introduced a number of innovative drugs
Time of Update: 2021-10-21
In the same year, Huadong Medicine established joint scientific research offices in Boston and Silicon Valley, and publicly stated that it would continue to increase R&D investment and accelerate the development of innovative drugs.
-
Shanghai Lu Xiangyi's high-quality centrifuge attracts repeat customers, and another batch of products are exported to Italy
Time of Update: 2021-10-21
Recently, an Italian customer reached a trade cooperation with Shanghai Lu Xiangyi and ordered a batch of nearly one hundred TD4 low-speed desktop centrifuge products .
-
AstraZeneca's global R&D China center set sail in Shanghai to help local innovation "go global"
Time of Update: 2021-10-21
According to Shanghai's plan, the city will promote the development of the biomedical industry in three aspects in the future, namely, researching core technologies, strengthening the layout of frontier fields, and strengthening the transformation of innovative achievements .
-
From the field of pharmaceutical equipment to daily chemicals, this pharmaceutical company has taken a "fancy" pace on the road of transformation!
Time of Update: 2021-10-21
The newly established company belongs to the field of daily chemicals, and its business scope is the sale of toothpaste, soap, synthetic detergent, disinfection products, health care products, oral cleaners, other oral and toothpaste cleaners; self-operating and agency sales of various products and technologies exports of cosmetics and other domestic business, material supply and marketing industry; bath products, shampoos, bath salts and other Japanese goods purchase and sale .
-
Pharmaceutical CDMO company Levi Pharmaceuticals obtains RMB 100 million in financing to speed up the construction of GMP base
Time of Update: 2021-10-20
It is understood that Rovi Pharmaceuticals was listed on the New Third Board in 2016 and received 100 million yuan in Series B financing in 2018 for the construction of a one-stop service platform for small molecule innovative drug production process research and development, process optimization, pilot and large-scale production.
-
A giant drugstore chain acquires another 12 stores to accelerate its deployment in the Hubei market
Time of Update: 2021-10-20
In recent years, the continuous increase of stores through "new construction + mergers and acquisitions" in order to achieve a larger market share and scale effect has become the core logic of the development of large chain pharmacies .
-
Another pharmaceutical company "out of the pit" in the cosmetics industry
Time of Update: 2021-10-20
The transfer involves 16 cosmetics trademarks held by Tai'antang, 10 cosmetics trademarks held by Shanghai Jinpibao Pharmaceutical, cosmetics-related formulation technology and cosmetics machinery and equipment .
-
Parkinson's treatment usher in new hope
Time of Update: 2021-10-19
Corresponding author of the paper, Aryn Gittis, associate professor of biological sciences at the school, said that this new study may change this situation .
But the Gittis team has succeeded in mice using a new DBS protocol that uses short-pulse electrical stimulation .
-
Discovery of new mechanisms for regulating blood lipid homeostasis, confirming new targets for lipid-lowering drugs
Time of Update: 2021-10-19
Discovery of new mechanisms for regulating blood lipid homeostasis, confirming new targets for lipid-lowering drugs Discovery of new mechanisms for regulating blood lipid homeostasis to confirm new targets for lipid-lowering drugs Schematic diagram of ASGR1 regulating lipid homeostasis https://doi.
1172/jci.
insight.
-
Chinese scientists reveal Venezuelan equine encephalitis virus binding receptor mechanism
Time of Update: 2021-10-19
It is worth noting that the researchers found that the mutation of amino acid at position 41 of LDLRAD3-D1 can increase the binding ability of the receptor to the virus by about 10 times, and has the potential to be a highly effective inhibitor of VEEV .
